Diabetes treatment instruments become a new hot spot in the medical device industry abroad

Business Club April 15th According to estimates by the World Health Organization (WHO), the total number of people with diabetes in the world has reached 136 million, and the total number of people with diabetes worldwide will reach 300 million by 2025. Over the past few decades, the international medical community has used diabetes therapy and controlled diets as the main treatment for diabetes. However, in recent years, the foreign medical device industry has set off an upsurge in the development of diabetes treatment devices. Nowadays, many new types of diabetes treatment devices have been developed and marketed abroad.

The "man-made pancreas" that controls postprandial hyperglycemia Researchers at Cambridge University in the United Kingdom have developed a new "artificial pancreas" consisting of a matchbox-sized blood glucose monitor and an insulin pump. People with type 1 diabetes can automatically measure the patient’s blood sugar changes by simply attaching the tester to the belt on the waist. Once the blood glucose is measured to rise too high, the detector will command the insulin pump to start and infuse insulin into the body so that the blood glucose returns to normal values. The use of this new type of diabetes treatment instrument can make type 1 diabetes relieve the worry of high blood sugar after meals.

The biggest disadvantage of the digital “smart insulin pen” traditional insulin pen is that the patient can only use the insulin pen according to the doctor's orders, but cannot independently determine the amount of insulin. Lilly introduced a new insulin pen product, the Digital Insulin Pen, last year. Its feature is that the pen can automatically store the insulin dose from the first 16 injections and give the best insulin dose plan for patient reference execution. Clinical trials in the United States and Europe have shown that 75% of people with diabetes use the new digital insulin pen product to achieve ideal blood glucose control and avoid postprandial hyperglycemia.

Implantable Ileus A medical device company in the United States has developed a novel diabetes treatment device called the Endo Barrier. The product is made of bio-plastic flexible film-type intestine, the doctor uses the intestinal endoscope to implant it in the small intestine and close to the intestinal wall. Its working principle is: to reduce the absorption of glucose and fat globules in the small intestine, so that the patient's weight loss, blood sugar levels decreased. Clinical trials in countries such as the Netherlands have shown that obese people with type 2 diabetes can lose 5 kg in weight within a few weeks after being implanted with the new product through a colonoscope. The most obvious benefit is that patients after the implantation of the new product after meals Blood glucose levels can be controlled within a reasonable range. According to reports, the price of implantable intestines (including doctor's surgery) is 2,000 US dollars, generally only 15 minutes to complete, without the need for surgery.

Insulin Film Pumps Insulin pumps are commonly used diabetes treatment devices. There are millions of diabetics worldwide who use insulin pumps every year. Traditional insulin pumps consist of an insulin reservoir and a few feet of tubing, which can be cumbersome to use. Meditronic, the largest medical device company in the United States, has developed a novel transdermal insulin pump product that looks like a thick adhesive plaster. Stick it on the skin to release insulin into the skin at regular intervals. More advanced is that the insulin mask agent can automatically determine the amount of insulin according to the level of blood sugar (with a biosensor) and is an intelligent insulin pump product.

Combining the two as a therapeutic device for diabetes Philips and Sony Corporation of Japan have collaborated to develop a novel diabetes treatment device. According to reports, this device combines the original electronic blood glucose meter and the insulin pump into one, through a special liquid contact with the patient's skin and then through the biosensor to detect blood sugar levels, and then determine whether to open by the analysis of the instrument data Insulin Pump. Some analysts believe that this blood glucose meter/insulin pump integrated diabetes treatment instrument is a new generation of revolutionary diabetes treatment instrument.

The advent of implantable electric pulse stimulation therapy ceramic piezoelectric new material has opened up a new era of implantable therapeutic devices. Foreign manufacturers use the new ceramic-metal coupling materials to develop an implanted pulse generator that is only 1/2 x 1/4 inch in size. Implanted into the abdominal fat layer of the abdomen of diabetics, it can send electrical pulse signals at regular intervals to stimulate the relevant nerves to promote or reduce the secretion of insulin, so that the blood glucose is within the ideal value range. Although this type of advanced implantable electric pulse signal generator is still in the development stage, once it enters the market through clinical trials, it will surely become a sharp weapon against the symptoms of intractable hyperglycemia.

Wireless 72 Hour Blood Glucose Tester The existing electronic blood glucose meter can only perform interval blood glucose measurement. However, some patients must continuously measure blood glucose fluctuations so that doctors can make correct treatment plans accordingly. Last year, Medtronics Medical Devices Inc. developed a new type of instrument that can continuously measure blood glucose levels in patients within 72 hours. The instrument consists of a highly sensitive biosensor and a small detector. It is very compact and can be inserted under the skin of the patient's abdomen. The patient will not feel pain. The instrument automatically measures the blood glucose level every 10 seconds and records it through the monitor. After 72 hours, the doctor took the patient's monitor for data analysis and obtained detailed information on the patient's daytime and nighttime blood glucose changes, which facilitates judgment of the condition and symptomatic treatment.